Short communicationPotential pitfalls in LC-MS/MS quantification of colistin for therapeutic drug monitoring of patients treated with colistimethate (cas 12705-41-8)
-
Add time:08/23/2019 Source:sciencedirect.com
Starting from a warning of possible artificially high plasma colistin concentrations observed in clinical samples in our recently published LC–MS/MS method, we reviewed our analytical assay and demonstrated, for the first time, that caution must be paid to ionization conditions employed in the MS system.The artefact reported here demonstrates that additional experiments should be performed in the course of validation of LC–MS/MS methods to be used in samples containing both colistin and colistimethate.
We also recommend Trading Suppliers and Manufacturers of colistimethate (cas 12705-41-8). Pls Click Website Link as below: cas 12705-41-8 suppliers
Prev:Heat capacity measurements on a thin ribbon sample of Zr0.55Al0.10Ni0.05Cu0.30 glassy alloy and Apiezon N (cas 12704-92-6) high vacuum grease using a Quantum Design Physical Property Measurement System
Next:Original ArticleSafety and effectiveness of sodium colistimethate (cas 12705-41-8)-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- NotesPolymyxin B and colistimethate (cas 12705-41-8) are comparable as to efficacy and renal toxicity08/28/2019
- Sodium colistimethate (cas 12705-41-8) loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis08/27/2019
- Rapid communicationStability of colistimethate (cas 12705-41-8) sodium in a disposable elastomeric infusion device08/26/2019
- Short communicationA simple method for assaying colistimethate (cas 12705-41-8) sodium in pharmaceutical aerosol samples using high performance liquid chromatography08/25/2019
- Original ArticleSafety and effectiveness of sodium colistimethate (cas 12705-41-8)-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration08/24/2019